Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L0LR
|
||||
| Former ID |
DIB015375
|
||||
| Drug Name |
UCL-67022
|
||||
| Synonyms |
HDAC inhibitor (multiple myeloma), ST Barts/UCL
|
||||
| Indication | Multiple myeloma [ICD9: 203; ICD10:C90] | Investigative | [543662] | ||
| Company |
University College London
|
||||
| Canonical SMILES |
c1cccc(c1)NC(=O)C(CCCCCC(=O)NO)C(=O)Nc1ccccc1
|
||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase 6 | Target Info | Inhibitor | [543662] | |
| KEGG Pathway | Alcoholism | ||||
| Viral carcinogenesis | |||||
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
| Signaling events mediated by HDAC Class I | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.